Abstract
The development of diagnostic tests for the botulinum neurotoxins is complicated by their extremely high potencies and the considerable diversity observed within the neurotoxin family. Current approaches for the detection of the toxins and the organism include amplified immunoassays and PCR techniques. Assays which exploit the biological activities within the botulinum toxins are also in development. These are based on both antibody and mass spectrometric techniques which measure the endopeptidase activities of the neurotoxins. This overview of theAssays and Detection Workshop of the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins discusses recent progress in the development of these assay systems and the issues that need to be overcome prior to their implementation.
Similar content being viewed by others
References
Andreadis, JD, JJ Kools, JD Dykes, JL Ferreira and SE Maslanka (2003) Development of an in vitro DIG-ELISA assay for detection ofClostridium botulinum neurotoxin serotypes A, B, E, and EASM Biodefense Research Conference, March 9-12, 2003 Baltimore, MD, USA.
Barr JR, VL Maggio, DG Patterson Jr, LO Henderson, GR Cooper, WH Hannon, LL Needham and EJ Sampson (1996) Isotope dilution-mass spectrometric method for the quantitation of specific proteins: model application with apolipoprotein A-1.Clin. Chem. 42, 1676–1682.
Barr JR, HM Moura, AE Boyer, AR Woolfitt, SR Kalb, A Pavlopoulous, LG McWilliams, JG Schmidt, RA Martinez and DL Ashley (2005) Botulinum neurotoxin detection and differentiation by mass spectrometry.Emerg. Infect. Dis. [serial on the Internet]. 2005 Oct. 11(10) Available from: http://www.cdc. gov/ncidod/EID/vol11no10/04-1279.htm.
Boyer AE, D Ash, DB Barr, CL Young, WJ Driskell, RD Whitehead Jr, M Ospina, KE Preston, AR Woolfitt, RA Martinez, LA Silks and JR Barr (2004) Quantitation of the sulfur mustard adducts 1,1’-sulfonylbis[2-(methylthio)ethane] and thiodiglycol in urine using isotope-dilution gas chromatography-tandem mass spectrometry.J. Anal. Toxicol. 28(5), 327–332.
Boyer AE, HM Moura, AR Woolfitt, SR Kalb, LG McWilliams, A Pavlopoulos, JG Schmidt, DL Ashley and JR Barr (2005) From the mouse to the mass spectrometer: Detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry.Anal. Chem. 77 (13), 3916–3924.
Doellgast GJ, MX Triscott, GA Beard, JD Bottoms, T Cheng, BH Roh, MG Roman, PA Hall and JE Brown (1993) Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay.J. Clin. Microbiol. 31, 2402–2409.
Ferreira JL, SJ Eliasberg, MA Harrison and P Edmonds (2001) Detection of preformed type A botulinal toxin in hash brown potatoes by using the mouse bioasssay and a modified ELISA test.J. AOAC Int. 84, 1460–1464.
Ferreira JL, SE Maslanka and JD Andreadis (2002) Detection of type A, B, E, and FClostridium botulinum toxins using digoxi-genin-labeled IgGs and the ELISA. DHHS/PHS/FDA Laboratory Information Bulletin No. 4292,1.
Ferreira JL, SE Maslanka, EA Johnson and M Goodnough (2003) Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: Collaborative Study.J. AOAC Int. 86, 314–331.
Franciosa G, JL Ferreira and CL Hatheway (1994) Detection of type A, B, and E botulism neurotoxin genes inClostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms.Clin. Microbiol. 32, 1911–1917.
Franciosa G, F Floridi, A Maugliani and P Aureli (2004) Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes inClostridium botulinum type A, Ab, and A(B) strains.Appl. Env. Micro. 70, 7192–7199.
Gibson AM, NK Modi, TA Roberts, CC Shone, P Hambleton and J Melling (1987) Evaluation of a monoclonal antibody-based immunoassay for detecting type AClostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.J. Appl. Bacteriol. 63, 217–226.
Hallis B, BAF James and CC Shone (1996) Development of novel assays for botulinum type A and B toxins based on their endopep-tidase activities.J. Clin. Microbiol. 34, 1934–1938.
Houen G and K Hansen (1997) Interference of sugars with the binding of biotin to streptavidin and avidin.J. Immunol. Methods 210, 115–123.
Hutson RA, Y Zhou, MD Collins, EA Johnson, CL Hatheway and H Sugiyama (1996) Genetic characterizationof Clostridium botulinum type A containing silent type B neurotoxin gene sequences.J. Biol. Chem. 271, 10786–10792.
Kalb SR, MC Goodnough, CJ Malizio, JL Pirkle and JR Barr (2005) Rapid detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin pro-teomics.J. Anal. Chem. 77, 6140–6146.
Jovita MR, MD Collins and AK East (1998) Gene organization and sequence determination of the 2 botulinum neurotoxin gene clusters inC. botulinum type A(B) strain NCTC2916.Curr. Micro. 36, 226–231.
Kimura B, S Kawasaki, H Nakano and T Fujii (2001) Rapid, quantitative PCR monitoring of growth ofClostridium botulinum type E in modified-atmosphere-packaged fish.Appl. Environ. Microbiol. 67, 206–216.
Lindstrom M, R Keto, A Markkula, M Nevas, S Hielm and H Korkeala (2001) Multiplex PCR assay for detection and identificationof Clostridium botulinum types A, B, E, and F in food and fecal material.Appl. Env. Micro. 67, 5694–5699.
Niemann H (1991) Molecular biology of clostridial neurotoxins, In:Sourcebook of Bacterial Protein Toxins (Alouf JE and JH Freer, Eds.) (Academic Press: London), pp 303–348.
Roman MG, JY Humber, PA Hall, NR Reddy, HM Solomon, MX Triscott, GA Beard, JD Bottoms, T Cheng and GJ Doellgast (1994) Amplified immunoassay ELISA-ELICA for measuringClostridium botulinum type E neurotoxin in fish fillets.J. Food Prot. 57, 985–990.
Schiavo G, M Matteoli and C Montecucco (2000) Neurotoxins affecting neuroexocytosis.Physiol. Rev. 80, 717–766.
Sharma SK and RC Whiting (2005) Methods for detection ofClostridium botulinum toxin in foods.J. Food Prot. 68(6), 1256–1263.
Smith TJ, J Lou, IN Geren, CM Forsyth, R Tsai, SL Laporte, WH Tepp, M Bradshaw, EA Johnson, LA Smith and JD Marks (2005) Sequence variation within botulinum neurotoxin sero-types impacts antibody binding and neutralization.Infect. Immunol. 73, 5450–5457.
Soloman HM, EJ Rhodehamel and DA Kautter (1995)Bacteriological Analytical Manual. 8th Edition, Chapter 17:Clostridium botulinum.
Stone WB and JC Okoniewski (2002) Botulism in Lake Erie.New York State Conservationist 56, 12.
Wictome M, K Newton, K Jameson, B Hallis, P Dunnigan, E Mackay, S Clarke, R Taylor, J Gaze, K Foster and C Shone (1999) Development of anin vitro bioassay forClostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.Appl. Environ. Microbiol. 65, 3787–3792.
Wictome M and CC Shone (1998) Botulinum neurotoxins: mode of action and detection.Symp. Ser. Soc. Appl. Microbiol. 27, 87S-97S. Review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shone, C., Ferreira, J., Boyer, A. et al. The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop Review: Assays and Detection. neurotox res 9, 205–216 (2006). https://doi.org/10.1007/BF03033940
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03033940